FDA investigators audited the WuXi Advanced Therapies - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 27 Dec 2002.
Product details
- Category: Biologics / Human Drugs / Medical Devices & Rad Health
- Inspection end: 27 Dec 2002
- Location: Philadelphia, United States
- FEI: 1000122198
